1. Akberova, N.I., Sravnenie dannykh. II. Neparametricheskie kriterii znachimosti (Data Comparison. II. Nonparametric Significance Tests), Kazan: Izd. Kaz. Gos. Univ., 2004.
2. Anisimov, A.G. and Bolotnikov, I.A., Treatment of synchronized K562 cells by tetrafluoroaluminate does not modulate the fluorescence of ethidium bromide and 4,6-diamidine-2-phenylindole in case of the binding with nucleoid DNA, Tsitologiya, 1999, vol. 41, no. 8, pp. 680–684.
3. Arleevskaya, M.I, Gabdulkhakova, A.G., and Tsibul’kin, A.P., Diagnosticheskie i prognosticheskie markery revmatoidnogo artrita s tochki zreniya patofiziologa (Diagnostic and Prognostic Markers of Rheumatoid Arthritis in Terms of Pathophysiology), Kazan: Ship, 2010.
4. Backer, M.V., Aloise, R., Przekop, K., Stoletov, K., and Backer, M.J.B., Molecular vehicles for targeted drug delivery, Bioconjugate Chem., 2002, vol. 13, pp. 462–467.
5. Biesenbach, P., Schmaldienst, S., Smolen, J.S., Hörll, W.H., Derfler, K., and Stummvoll, G.H., Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity, Atherosclerosis Supplements, 2009, vol. 10, pp. 114–121.